File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: Antimicrobial treatment of peri-implant diseases

TitleAntimicrobial treatment of peri-implant diseases
Authors
Issue Date2004
PublisherQuintessence Publishing Co, Inc. The Journal's web site is located at http://www.quintpub.com/journals/omi/gp.php?journal_name=OMI&name_abbr=IJOMI
Citation
International Journal Of Oral And Maxillofacial Implants, 2004, v. 19 SUPPL., p. 128-139 How to Cite?
AbstractPurpose: To review the literature on the treatment of peri-implant diseases. Specific emphasis was placed on the use of antimicrobial therapy, defined as local or systemic administration of antiseptic and/or antibiotic agents. Materials and Methods: A search of MEDLINE, the Cochrane Controlled Trials Register, and The Cochrane Health Group Specialized Register was conducted, and articles published in English until July 31, 2003, were included. The results of experimental animal studies and human research are presented. Results: A variety of antimicrobial treatment regimens in combination with nonsurgical or surgical debridement with and without regenerative therapy were reported. Use of antimicrobials varied between studies with respect to type of drug, dosage, delivery system, duration, and commencement of antibiotic administration. Patient compliance and adverse effects related to the antimicrobials were mostly not mentioned. Discussion: While the majority of the case reports and studies presented showed positive outcomes following antimicrobial treatment, there were no non-medicated controls included, so the relative effect of the antimicrobial agent(s) cannot be evaluated. Conclusions: Although antimicrobials are widely used for the treatment of peri-implant diseases, evidence of their benefit is limited, and randomized, controlled human trials should be initiated where ethically possible. In addition, prospective cohort studies designed to monitor consecutive cases treated using specific treatment protocols are required.
Persistent Identifierhttp://hdl.handle.net/10722/157948
ISSN
2015 Impact Factor: 1.859
2015 SCImago Journal Rankings: 0.671
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorHeitzMayfield, LJAen_US
dc.contributor.authorLang, NPen_US
dc.date.accessioned2012-08-08T08:57:07Z-
dc.date.available2012-08-08T08:57:07Z-
dc.date.issued2004en_US
dc.identifier.citationInternational Journal Of Oral And Maxillofacial Implants, 2004, v. 19 SUPPL., p. 128-139en_US
dc.identifier.issn0882-2786en_US
dc.identifier.urihttp://hdl.handle.net/10722/157948-
dc.description.abstractPurpose: To review the literature on the treatment of peri-implant diseases. Specific emphasis was placed on the use of antimicrobial therapy, defined as local or systemic administration of antiseptic and/or antibiotic agents. Materials and Methods: A search of MEDLINE, the Cochrane Controlled Trials Register, and The Cochrane Health Group Specialized Register was conducted, and articles published in English until July 31, 2003, were included. The results of experimental animal studies and human research are presented. Results: A variety of antimicrobial treatment regimens in combination with nonsurgical or surgical debridement with and without regenerative therapy were reported. Use of antimicrobials varied between studies with respect to type of drug, dosage, delivery system, duration, and commencement of antibiotic administration. Patient compliance and adverse effects related to the antimicrobials were mostly not mentioned. Discussion: While the majority of the case reports and studies presented showed positive outcomes following antimicrobial treatment, there were no non-medicated controls included, so the relative effect of the antimicrobial agent(s) cannot be evaluated. Conclusions: Although antimicrobials are widely used for the treatment of peri-implant diseases, evidence of their benefit is limited, and randomized, controlled human trials should be initiated where ethically possible. In addition, prospective cohort studies designed to monitor consecutive cases treated using specific treatment protocols are required.en_US
dc.languageengen_US
dc.publisherQuintessence Publishing Co, Inc. The Journal's web site is located at http://www.quintpub.com/journals/omi/gp.php?journal_name=OMI&name_abbr=IJOMIen_US
dc.relation.ispartofInternational Journal of Oral and Maxillofacial Implantsen_US
dc.subject.meshAnimalsen_US
dc.subject.meshAnti-Infective Agents - Therapeutic Useen_US
dc.subject.meshDental Implantation, Endosseous - Adverse Effectsen_US
dc.subject.meshDental Implants - Adverse Effects - Microbiologyen_US
dc.subject.meshHumansen_US
dc.subject.meshMouth Mucosaen_US
dc.subject.meshPeriodontitis - Drug Therapy - Etiologyen_US
dc.subject.meshProsthesis-Related Infections - Drug Therapy - Etiologyen_US
dc.subject.meshStomatitis - Drug Therapy - Etiologyen_US
dc.titleAntimicrobial treatment of peri-implant diseasesen_US
dc.typeConference_Paperen_US
dc.identifier.emailLang, NP:nplang@hkucc.hku.hken_US
dc.identifier.authorityLang, NP=rp00031en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.pmid15635953-
dc.identifier.scopuseid_2-s2.0-12244264211en_US
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-12244264211&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume19en_US
dc.identifier.issueSUPPL.en_US
dc.identifier.spage128en_US
dc.identifier.epage139en_US
dc.identifier.isiWOS:000226100500013-
dc.publisher.placeUnited Statesen_US
dc.identifier.scopusauthoridHeitzMayfield, LJA=6602309146en_US
dc.identifier.scopusauthoridLang, NP=7201577367en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats